News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
725,782 Results
Type
Article (42916)
Company Profile (297)
Press Release (682568)
Multimedia
Podcasts (93)
Webinars (15)
Section
Business (210622)
Career Advice (2095)
Deals (36675)
Drug Delivery (108)
Drug Development (83172)
Employer Resources (175)
FDA (16661)
Job Trends (15447)
News (356488)
Policy (34006)
Tag
Academia (2600)
Accelerated approval (12)
Adcomms (23)
Allergies (104)
Alliances (51579)
ALS (116)
Alzheimer's disease (1503)
Antibody-drug conjugate (ADC) (164)
Approvals (16666)
Artificial intelligence (333)
Autoimmune disease (31)
Automation (20)
Bankruptcy (372)
Best Places to Work (11770)
BIOSECURE Act (20)
Biosimilars (131)
Biotechnology (188)
Bladder cancer (96)
Brain cancer (38)
Breast cancer (385)
Cancer (3011)
Cardiovascular disease (232)
Career advice (1758)
Career pathing (31)
CAR-T (192)
CDC (34)
Cell therapy (519)
Cervical cancer (23)
Clinical research (68568)
Collaboration (1082)
Company closure (3)
Compensation (717)
Complete response letters (31)
COVID-19 (2706)
CRISPR (65)
C-suite (365)
Cystic fibrosis (118)
Data (3173)
Decentralized trials (2)
Denatured (31)
Depression (68)
Diabetes (353)
Diagnostics (6522)
Digital health (23)
Diversity (9)
Diversity, equity & inclusion (45)
Drug discovery (149)
Drug pricing (138)
Drug shortages (31)
Duchenne muscular dystrophy (149)
Earnings (89412)
Editorial (44)
Employer branding (21)
Employer resources (151)
Events (116789)
Executive appointments (880)
FDA (18459)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (964)
Gene editing (141)
Generative AI (24)
Gene therapy (411)
GLP-1 (835)
Government (4649)
Grass and pollen (6)
Guidances (214)
Healthcare (19024)
HIV (40)
Huntington's disease (31)
IgA nephropathy (41)
Immunology and inflammation (166)
Immuno-oncology (10)
Indications (42)
Infectious disease (2887)
Inflammatory bowel disease (154)
Inflation Reduction Act (10)
Influenza (69)
Intellectual property (126)
Interviews (323)
IPO (16870)
IRA (53)
Job creations (4064)
Job search strategy (1494)
Kidney cancer (13)
Labor market (55)
Layoffs (526)
Leadership (20)
Legal (8402)
Liver cancer (80)
Longevity (12)
Lung cancer (419)
Lymphoma (219)
Machine learning (11)
Management (59)
Manufacturing (437)
MASH (97)
Medical device (13565)
Medtech (13571)
Mergers & acquisitions (20541)
Metabolic disorders (883)
Multiple sclerosis (100)
NASH (17)
Neurodegenerative disease (139)
Neuropsychiatric disorders (37)
Neuroscience (2236)
NextGen: Class of 2025 (6642)
Non-profit (4537)
Now hiring (50)
Obesity (445)
Opinion (243)
Ovarian cancer (103)
Pain (126)
Pancreatic cancer (129)
Parkinson's disease (190)
Partnered (22)
Patents (323)
Patient recruitment (180)
Peanut (53)
People (59746)
Pharmaceutical (91)
Pharmacy benefit managers (23)
Phase I (21259)
Phase II (30172)
Phase III (22600)
Pipeline (1734)
Policy (221)
Postmarket research (2655)
Preclinical (9078)
Press Release (68)
Prostate cancer (145)
Psychedelics (38)
Radiopharmaceuticals (259)
Rare diseases (496)
Real estate (6268)
Recruiting (68)
Regulatory (23633)
Reports (50)
Research institute (2376)
Resumes & cover letters (359)
Rett syndrome (9)
RNA editing (10)
RSV (52)
Schizophrenia (99)
Series A (162)
Series B (112)
Service/supplier (12)
Sickle cell disease (65)
Special edition (19)
Spinal muscular atrophy (151)
Sponsored (33)
Startups (3741)
State (2)
Stomach cancer (15)
Supply chain (79)
Tariffs (69)
The Weekly (60)
Vaccines (818)
Venture capital (56)
Weight loss (277)
Women's health (47)
Worklife (16)
Date
Today (132)
Last 7 days (535)
Last 30 days (1799)
Last 365 days (31495)
2025 (18118)
2024 (35771)
2023 (40630)
2022 (51798)
2021 (56330)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33136)
2016 (32663)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (787)
Alabama (63)
Alaska (7)
Arizona (251)
Arkansas (14)
Asia (41166)
Australia (6581)
California (7678)
Canada (2439)
China (708)
Colorado (325)
Connecticut (327)
Delaware (204)
Europe (88018)
Florida (1163)
Georgia (257)
Hawaii (2)
Idaho (60)
Illinois (669)
India (29)
Indiana (379)
Iowa (17)
Japan (245)
Kansas (110)
Kentucky (29)
Louisiana (15)
Maine (64)
Maryland (1056)
Massachusetts (5759)
Michigan (252)
Minnesota (468)
Mississippi (4)
Missouri (95)
Montana (28)
Nebraska (25)
Nevada (84)
New Hampshire (67)
New Jersey (2145)
New Mexico (29)
New York (2145)
North Carolina (1120)
North Dakota (8)
Northern California (3394)
Ohio (242)
Oklahoma (16)
Oregon (39)
Pennsylvania (1672)
Puerto Rico (17)
Rhode Island (37)
South America (1164)
South Carolina (35)
South Dakota (1)
Southern California (2886)
Tennessee (128)
Texas (1174)
United States (28562)
Utah (224)
Virginia (203)
Washington D.C. (72)
Washington State (655)
West Virginia (4)
Wisconsin (70)
725,782 Results for "citius pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update
May 15, 2025
·
12 min read
Press Releases
Citius Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
May 5, 2025
·
2 min read
Press Releases
Citius Oncology Announces Closing of $9.0 Million Public Offering
July 18, 2025
·
6 min read
Press Releases
Citius Oncology, Inc. Reports Fiscal Second Quarter 2025 Financial Results and Provides Business Update
May 14, 2025
·
9 min read
Press Releases
Citius Oncology Anticipates Commercial Launch of LYMPHIR™ in 2025
June 18, 2025
·
16 min read
Press Releases
Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora
July 16, 2025
·
14 min read
Press Releases
Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update
February 17, 2025
·
12 min read
Press Releases
Citius Pharmaceuticals Announces Closing of Registered Direct Offering of Up To $15.8 Million Priced At-The-Market Under Nasdaq Rules
June 13, 2025
·
6 min read
Business
Citius Pharmaceuticals, Inc. Reports Fiscal Second Quarter 2024 Financial Results and Provides Business Update
Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today reported business and financial results for the fiscal second quarter 2024 ended March 31, 2024.
May 14, 2024
·
13 min read
Press Releases
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update
December 29, 2024
·
13 min read
1 of 72,579
Next
